Ghallab, D. S. Et Al. 2022. Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat. RSC ADVANCES , vol.12, no.5 , 2843-2872.

Ghallab, D. S., Shawky, E., Metwally, A. M., ÇELİK, İ., Ibrahim, R. S., & Mohyeldin, M. M., (2022). Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat. RSC ADVANCES , vol.12, no.5, 2843-2872.

Ghallab, Dina Et Al. "Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat," RSC ADVANCES , vol.12, no.5, 2843-2872, 2022

Ghallab, Dina S. Et Al. "Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat." RSC ADVANCES , vol.12, no.5, pp.2843-2872, 2022

Ghallab, D. S. Et Al. (2022) . "Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat." RSC ADVANCES , vol.12, no.5, pp.2843-2872.

@article{article, author={Dina S. Ghallab Et Al. }, title={Integrated in silico - in vitro strategy for the discovery of potential xanthine oxidase inhibitors from Egyptian propolis and their synergistic effect with allopurinol and febuxostat}, journal={RSC ADVANCES}, year=2022, pages={2843-2872} }